Mechanism Study on the Treatment of Pelvic Pain in Endometriosis by Qu Yu Jie Du Xiao Zheng Decotion in Combination with Dextroprogesterone
article
OA: hybrid
CC0
Abstract
This study aimed to evaluate the clinical efficacy and effect on serum levels of PGE2, NGF and TNF-α of the combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone in treating pelvic pain in patients with endometriosis. Sixty patients were randomly divided into three groups: Chinese medicine group, Western medicine group, and combination group. After treatment, the combination group showed significant relief of pain, and the apparent efficacy of menstrual pain, pelvic pressure pain, and palpable nodules was 70%, 83.33%, and 61.54%, respectively, which was significantly higher than that of the other two groups. There were significant differences in serum TNF-α, NGF and PGE2 levels among the three groups after treatment. The conclusion was that the combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone could significantly improve the immune function of patients with endometriosis, regulate levels of nerve growth factor, tumor necrosis factor, and prostaglandin E2, thereby relieving pain.
Full text
27,290 characters
· extracted from
oa-pdf
· 4 sections
· click to expand
Keywords
Endometriosis, Qu Yu Jie Du Xiao Zheng Decotion, Deferiprone, Tumor
Necrosis Factor, Prostaglandins, Nerve Growth Factor
Abstract
This study aimed to evaluate the clinical efficacy and effect on serum levels of
PGE2, NGF and TNF -α of the combination of Qu Yu Jie Du Xiao Zheng Decotion and
Dydrogesterone in treating pelvic pain in patients with endometriosis . Sixty patients were
randomly divided into three groups: Chinese medicine group, Western medicine group, and
combination group. After treatment, the combination group showed significant relief of
pain, and the apparent efficacy of menstrual pain, pelvic pressure pain, and palpable
nodules was 70%, 83.33%, and 61.54%, respectively, which was significantly higher than
that of the other two groups. There were significant differences in serum TNF-α, NGF and
PGE2 levels among the three groups after treatment. The conclusion was that the
combination of Qu Yu Jie Du Xiao Zheng Decotion and Dydrogesterone could
significantly improve the immune function of patients with endometriosis , regulate levels
of nerve growth factor, tumor necrosis factor, and prostaglandin E2, thereby relieving pain.
1. Introduction
Endometriosis (EMs) is a gynecological disease caused by endometrial growth in the uterus and
other extra-uterine parts, which mostly occurs in women aged 20-45 years old, and the incidence of
this disease has been on the rise in recent years [1].EMs can infiltrate other organs in the patient's
pelvic cavity, and has the characteristics of proliferation, hyperplasia, and metastasis, with clinical
manifestations such as pelvic pain and infertility, which seriously affect the patient's health and
quality of life [2].For the treatment of EMs, Western medicine mainly adopts sex hormone therapies
such as progesterone, contraceptive pills, and mifepristone to achieve the purpose of relieving pain
by inhibiting ovulation, which has a better effect on symptomatic improvement in the short term,
but is prone to drug resistance, and the symptoms are easy to recur after discontinuing the drug
[3].In Chinese medicine, this disease belongs to the category of "dysmenorrhea" and "symptoms".
In recent years, many scholars believe that the pathogenesis of EMs is stasis of blood, evil blood
congestion in the uterus and veins of the uterus, which becomes toxic over time and is transformed
into stasis of toxins, and advocate that this disease should be treated with the method of eliminating
MEDS Basic Medicine (2023)
Clausius Scientific Press, Canada
DOI: 10.23977/medbm.2023.010214
ISSN 2616-2091 Vol. 1 Num. 2
89
stasis of blood and removing toxins [4]. In the present study, in order to enhance the efficacy of
EMs, the treatment of Qu Yu Jie Du Xiao Zheng decotion was added on the basis of conventional
western medicine treatment, which is now reported as follows.
2. Information and Methods
In this study, a total of sixty patients diagnosed with EMs were selected from the gynecology
outpatient clinic of Xi'an Hospital of Traditional Chinese Medicine between January 2022 and
December 2022. The random assignment of patients to different treatment groups, namely A:
Traditional Chinese medicine group, B: Western medicine group, and C: Combination of Chinese
and Western medicine group, was conducted using the random number generation algorithm in
SPSS22.0 statistical software. The age range of the traditional Chinese medicine group was between
25 and 44 years, with an average age of 33.95± 4.23 years. The duration of the disease varied from
0.4 to 5 years, with an average duration of 2.07± 1.15 years. The body mass index ranged from 19.8
to 26, with a mean body mass index of 22.28± 1.34. In the western medicine group, the age range
was between 22 and 25 years, with a mean age of 32.55± 6.75 years. The disease d uration varied
from 0.5 to 4 years, with an average duration of 1.85± 1.18 years. The body mass index ranged from
18.9 to 27, with a mean body mass index of 22.72± 1.95. In the group combining Chinese and
Western medicines, the age range was between 25 and 45 years, with a mean age of 33.5± 5.63 years.
The disease duration varied from 1 to 6 years, with an average duration of 2.35± 1.31 years. The
body mass index ranged from 19 to 26, with a mean body mass index of 22.32± 1.49. After
conducting a χ2 test, the di fference between the baseline data of the three groups was not
statistically significant (P>0.05), and was considered comparable.
The inclusion criteria for this study were as follows: ①
Patients with endometriosis who met
both the clinical diagnostic crit eria of Western medicine [5] and the Chinese medicine diagnosis of
"stasis, toxicity, dampness and turbidity" [6]; ② Patients who did not have plans for pregnancy
within the next year; ③ Patients who voluntarily agreed to participate in the study and signe d the
informed consent form; ④ Patients who had previously undergone treatment with hormonal drugs
or conservative surgical treatments, and had ceased usage for a minimum of three months; or
patients who had received traditional Chinese medicine (TCM) trea tment for at least three months;
or patients who had previously received TCM treatment, but had stopped using the medicine for at
least one month and still met the aforementioned diagnostic criteria.
The exclusion criteria for this study encompass various medical conditions, which include severe
uterine fibroids, cardiovascular and cerebrovascular diseases, hepatic and renal diseases, as well as
hematopoietic system diseases. Additionally, patients with psychiatric disorders and those who have
demonstrated allergies to the drug being tested, as well as the control drug, are also excluded.
Furthermore, individuals who fail to meet the inclusion criteria, fail to adhere to the drug usage
criteria, or have incomplete data that may hinder the assessment of thera peutic efficacy and safety
are also excluded.
Treatment ①
The oral Qu Yu Jie Du Xiao Zheng decoction in the Traditional Chinese medicine
group consists of various herbal ingredients. These include 30g of Sargentgloryvine Stem , 30g of
Hedyotis diffusa, 30g of Coix seed, 30g of Astragalus membranaceus, 15g of Corrugated wood, 15g
of Litchi seed (broken), 10g of Pseudobulbus Cremastrae seu Pleiones (broken), 9g of Agastache
rugosus (after the lower part of the head), 2 Centipede (with head and feet removed), 6g of Resina
draconis, 6g of Eupolyphaga, 6g of Olibanum, 6g of Myrrha, and 6g of Radix Glycyrrhizae
Preparata[7]. The Xi'an Hospital of Traditional Chinese Medicine's Pharmacy Center prepared a
decoction, while the Traditional Chinese Medicine Decoction R oom provided the broth, in the
amount of 200mL per bag. The recommended dosage is one bag, two times a day, in the morning
90
and evening. It is important to note that no other medications should be taken for this condition
during the treatment period. Additi onally, the consumption of cold drinks, oily foods, and
stimulating foods should be minimized while taking this medication. If a cold is contracted, the
medication should be immediately discontinued. In the event of pregnancy during treatment, the
medication should also be stopped immediately. Individuals with allergies to Chinese medicine are
prohibited from using this medication, and those who are allergic should exercise caution. ②
Western medicine group: Daflon (Diflucan tablets Abbott Biologicals B.V . (Netherlands)) should be
administered at a dosage of 10mg per intake, twice daily, starting from the fifth day of the menstrual
cycle and continuing for a duration of 20 days. It is necessary to undergo a consecutive treatment
regimen for three menstrual cy cles. It is important to note that the concomitant use of other
medications with similar effects is strictly contraindicated during the treatment period. ③
Combination of Chinese and Western medicines group: the administration method of oral Chinese
medicine is similar to that of the Chinese medicine group. Additionally, dydrogesterone tablets are
orally administered starting on the 5th day of menstruation, following the dosage and administration
Method
of the Western medicine group. There is no combined me dication involved.Observation
indicators
Pelvic pain scores: The "Pelvic Pain Assessment Scale" [8] was utilized by patients to document
various aspects of their pain. These included menstrual pain, encompassing abdominal and breast
pain, as well as lumba r pain before and after menstruation, and symptoms of anal irritation during
menstruation. Additionally, scores were assigned to other pelvic pain symptoms, such as
non
-menstrual pelvic pain, pain during intercourse, and anal cramps. The severity of menstr ual pain
and non-menstrual pelvic pain was measured using the Visual Analog Scale (V AS) before and after
treatment for all three patient groups.
Serum factor levels: ELISA was used to detect the levels of nerve growth factor (NGF),
prostaglandin E2 (PGE2) and tumor necrosis factor -alpha (TNF-α) in the peripheral blood in the
serum before and after treatment, and the experimental process was carried out in strict accordance
with the instructions.
In this experiment, percent efficacy was used to assess the tr eatment effect. The formula for
calculating the percentage of efficacy was (pre -treatment points - post-treatment
points)/pre-treatment points)× 100%. According to the calculated percentage of efficacy, the efficacy
was categorized into four grades: cured, obvious, effective and ineffective. The specific efficacy
evaluation criteria are as follows:
① Cured: after drug intervention, various clinical symptoms disappeared, such as pelvic masses,
tender nodules and other local signs basically disappeared. The percentage of efficacy (N) is greater
than or equal to 95% [9].
② Significant effect: clinical symptoms basically disappeared and pelvic mass was reduced
(compared with gynecological examination and pelvic ultrasound examination at the same time of
menstrual cycle). The percentage
of efficacy is 95% greater than N greater than or equal to 70%.
③ Effective: Symptoms are relieved and pelvic lesions are not significantly enlarged or slightly
reduced. The percentage of efficacy is 70% greater than N greater than or equal to 30%.
Ineffective: no change or aggravation of the main symptoms, local lesions have a tendency to
aggravate. The percentage of efficacy (N) is less than 30%.
According to the above criteria, patients can be categorized into different levels a ccording to the
efficacy percentage to assess the effectiveness of treatment.
Statistical methods In this experiment, SPSS 22.0 statistical software was used to process the
obtained data. For the general data of the three groups of patients, the chi -square test was used to
analyze the count data, while for the measurement data, the variance chi -square test was performed
first, and then the independent samples t -test was used to compare the differences between the
91
groups, while the paired samples t -test was used to compare the differences between the groups.
When the p-value is less than 0.05, it means that the difference is statistically significant.
3. Results
3.1 Comparison of VAS Scores among the 3 Groups See Table 1.
Table 1
. Comparison of VAS scores in 3 groups (x± s, points)
Group Number of cases Before treatment After treatment Before and after difference
(D value)
Chinese medicine group 20 5.83± 1.95 2.8± 1.05 3.03± 1.55
Western medicine group 20 5.60± 2.14 3.05± 1.36 2.55± 1.75
Chinese and Western medicine
Combined group 20 6.10± 1.80 1.95± 1.05 4.15± 1.43
As can be seen from Table 1, the V AS scores of the three groups had different decreases after
treatment. After t -test, the difference between the points of the combined Chinese and Western
medicine group compared with the Chinese medicine group and the Western medicine group was
extremely significant (p the difference of the Chinese medicine group > the difference of the Western medicine
group, which indicated that in terms of the effect of pain relief, the combined Chinese and Western
medicine group had a better effect than the other two groups.
3
.2 Comparison of Pelvic Pain Efficacy after Treatment in the 3 Gr oups See Table 2.
Table 2. Comparison of the effective rate of pelvic pain treatment among 3 groups of patients
Symptoms Group Number of cases Disappearance rate
Menstrual abdominal
pain
Chinese medicine group 19 9 (47.36%)
Western medicine group 17 7 (41.11%)
Chinese and Western medicine
Combined group 20 14(70.00%)
Lumbosacral pain
Chinese medicine group 15 7 (46.67%)
Western medicine group 18 8 (44.44%)
Chinese and Western medicine
Combined group 15 10(66.67%)
Pelvic pressure pain
Chinese medicine group 18 10(55.56%)
Western medicine group 19 9(47.37%)
Chinese and Western medicine
Combined group 18 15(83.33%)
Sexual intercourse
pain
Chinese medicine group 11 7(63.64%)
Western medicine group 14 8(57.14%)
Chinese and Western medicine
Combined group 12 10(83.30%)
Anal pain
Chinese medicine group 13 8(61.54%)
Western medicine group 11 6(54.55%)
Chinese and Western medicine
Combined group 14 11(78.57%)
Tender nodules
Chinese medicine group 12 5(41.67%)
Western medicine group 15 7(46.67%)
Chinese and Western medicine
Combined group 13 8(61.54%)
92
As can be seen from Table 2, after treatment, the apparent efficacy rates of menstrual abdominal
pain, pelvic pressure pain, and tender nodules of the patients in the combination of Chinese and
Western medicines group were 70%, 83.33%, and 61.54%, respectively, which were higher than
those of the rest of the two groups, and the difference between the apparent efficacy rates of pelvic
pain of the combination of Chinese and Western medicines treatment group compared with the
Chinese medicine treatment group and the Western medicine treatment group was extremely
significant after the χ2 test (p<0.01); after treatment, the apparent efficacy rates of intercourse pain,
lumbosacral pain, anal pain of patients in the After the treatment, the apparent efficiency of sexual
intercourse pain, lumbosacral cramps and anal cramps of the patients in the combined group was
also higher than that of the remaining two groups, but the difference was not statistically significant,
which indicated that the combination of traditional Chinese and Western medicines group could
achieve effective relief of pelvic pain.
3.3
Comparison of Serum TNF-α, NGF and PGE2 Levels before and after Treatment in the 3
Groups See Table 3.
Table 3. Comparison of serum TNF-α, NG F and PGE2 levels before and after treatment in 3 groups
of patients
As shown in the above table, the difference in serum TNF- α, NGF and PGE2 levels between the
three groups before and after treatment was statistically significant (p < 0.05 or p < 0.01), in
addition, the difference in TNF- α, NGF and PGE2 levels after treatment between the weste rn
medicine group and the combination of western and traditional Chinese medicines group was
statistically significant (p < 0.05), and the difference between the Chinese and western medicine
group after treatment TNF- α, NGF and PGE2 levels after treatment in the Chinese medicine group
and the combination of Chinese and Western medicines group, the difference was statistically
significant (P < 0.05), while the difference was not statistically significant in the comparison of
TNF-α, NGF and PGE2 levels after treatment in the Chinese medicine group and the combination
of Chinese and Western medicines group (P > 0.05).
Item Chinese medicine
group (n=20)
Western medicine
group (n=20)
Chinese and Western
medicine
Combined group(n=20)
F value P value
TNF-α
Before
treatment 11.94± 1.33 11.86± 2.54 11.52± 1.96 0.268 0.767
Post-treat
ment 10.54± 1.75 9.15± 3.58 7.87± 3.30 3.416 0.038
NGF
Before
treatment 89.97± 9.39 80.81± 17.31 90.62± 10.60 2.140 0.134
Post-treat
ment 72.15± 12.56 66.23± 14.06 64.07± 26.40 4.901 0.014
PGE2
Before
treatment 95.318± 8.790 95.01± 12.77 98.04± 9.43 0.307 0.738
Post-treat
ment 81.620± 15.33 79.87± 18.07 63.51± 26.68 6.453 0.004
93
4. Discussion
Effect of Qu Yu Jie Du Xiao Zheng decotion in Combination with Dydrogesterone Tablets on
Pelvic Pain The results of this study showed that after the intervention of Qu Yu Jie Du Xiao Zheng
decotion in Combination with Dydrogesterone Tablets, the patients' pelvic pain was significantly
improved, and the significant scores of dysmenorrhea, pelvic tenderness and palpable nodules were
higher than those of dysmenorrhea, pelvic pain, and palpable nodules of the rest of the two groups
with a statistically significant difference (P<0.05), which confirms that Qu Yu Jie Du X iao Zheng
decotion can also effectively relieve other symptoms such as pain during sexual intercourse and
anal pain.
Effects of Qu Yu Jie Du Xiao Zheng decotion in combination with Difluprednate Tablets on the
levels of TNF -α, NGF and PGE2 in the serum of the patients Modern medicine believes that
endometriosis is a kind of intractable disease, and the mechanism of its pathogenesis is extremely
complex, which has not been completely clarified, and is currently dominated by the retrograde
flow of menstrual blood and the implantation theory [10], that is, the fragments of the endometrium
retrograde flow of menstrual blood and enter the pelvic cavity via the fallopian tubes, and then are
planted in the ovary or other parts of the pelvic cavity [11]. or other pa rts of the pelvis [11]. Pelvic
pain is one of the main symptoms of endometriosis, and the mechanism by which it arises is a
complex process. Studies have shown that immunoinflammatory factors, estrogen levels, nerve
growth factors, and serum prostaglandins are closely related to the occurrence of
endometriosis-related pain. It has been found that ectopic endothelial tissue can secrete nerve
growth factor (NGF) [12], and activated macrophages can produce a large amount of tumor necrosis
factor (TNF-) and increase the level of cyclooxygenase-2 (COX2), which in turn increases the level
of prostaglandins, which in turn increases the level of prostaglandins. The activated mast cells can
degranulate and secrete TNF - and PGs [13]. Therefore, the serum levels of TNF -, NGF and PGE2
are higher in patients with endografts. According to the results of this experiment, the levels of
TNF-α, NGF and PGE2 in the serum of patients in the combined Chinese and Western medicine
group were significantly lower after treatment comp ared with those before treatment, and the
difference was statistically significant (P < 0.01). Meanwhile, there were significant differences
between the Western medicine group and the combined Chinese and Western medicine group in the
levels of TNF -α, NGF and PGE2 after treatment (P < 0.05). Significant differences also existed
between the TCM group and the combined TCM and Western medicine group in the levels of
TNF-α, NGF and PGE2 after treatment (P 0.05). This suggests that the combination of Qu Yu Jie Du Xiao
Zheng decotion and Difenocoumarol Tablets was able to regulate the le vels of TNF -α, NGF and
PGE2 in the serum of the patients, which significantly alleviated the pain of pelvic pain in patients
with endogamy.
Legislative basis for the treatment of endometriosis byQu Yu Jie Du Xiao Zheng decotion in
combination with dextroprogesterone tablets Endometriosis is an estrogen -dependent disease, for
which Western medicine drug therapy is mainly given as hormonal thera pies (progestins, birth
control pills, sex hormones such as mifepristone). Deferiprogesterone is a progestin, which can
inhibit endometrial hyperplasia, shrink the ectopic endometrium, and further inhibit the
development of ectopic foci [14]. Endometriosis belongs to the category of "dysmenorrhea" and
"obstruction in the abdomen" in traditional Chinese medicine (TCM). TCM believes that the core of
this disease is "blood stasis", so the treatment is based on activating blood circulation and
eliminating blood stasis. In recent years, some scholars believe that the basic pathology of EMs is
not only "blood stasis", but also "turbid fluid", and that both of them can not only be brewed into
94
stasis toxin and dampness toxin for a long period of time, but also fumigate with each other and turn
into heat toxin. In the previous project, we have formulated Qu Yu Jie Du Xiao Zheng decotion,
which has the function of dispelling blood stasis, resolving toxins and removing turbidities, and
eliminating crushing and dispersin g lumps and knots, to treat dysmenorrhea and obstruction in the
abdomen of internal heterotaxy, and it has achieved good therapeutic effect. In this experiment, in
order to improve the efficacy of EMS, the formula of Qu Yu Jie Du Xiao Zheng decotion was added
on the basis of oral administration of dydrogesterone tablets, in which all the medicines in the
formula were combined together to eliminate and remit the evil toxins in an all -rounded way and at
various levels, such as clearing away heat and detoxific ation, dispelling blood stasis, removing
dampness and resolving turbidities and toxins, clearing up the channels of the worms and
eliminating the toxicity and alleviating the toxicity by benefiting the qi to support the toxins and
relieving toxicity throug h the glycytes and the toxins, so as to eliminate blood stasis and clear up
channels of the worms and resolving turbidities and eliminating symptoms and alleviating pain [15].
The results of this study also proved that the difference in V AS scores before a nd after treatment
between Qu Yu Jie Du Xiao Zheng decotion in combination with dydrogesterone tablets was more
obvious compared with the traditional Chinese medicine group and the western medicine group
(P<0.05), and the improvement of pelvic pain in the combination of traditional Chinese medicine
and western medicine group was more significant than that in the rest of the two groups, which
suggests that the addition of Qu Yu Jie Du Xiao Zheng decotion in combination with
dydrogesterone tablets can enhance the effect of improving pelvic pain. The difference in serum
TNF-α, NGF and PGE2 levels between the Chinese and Western medicine combination group
before and after treatment was statistically significant (P < 0.01), confirming that the combination
of Qu Yu Jie Du Xiao Zheng decotion and dydrogesterone tablets could regulate the serum levels of
TNF-α, NGF and PGE2 in patients with endogenous syndrome.
In conclusion, the combination of Qu Yu Jie Du Xiao Zheng decotion with dydrogesterone
tablets can regulate the serum levels of TNF-α, NGF and PGE2 in patients, effectively improve the
symptoms of pelvic pain in patients with endometriosis, and the effect is remarkable, which
provides a new way of thinking for the treatment of endometriosis pain.
Funding
Health
Research Talent Program of Xi'an Municipal Health Planning Commission (2022yb02)
References
[1] Sun A’ mei, Liu Changyun, Liu Hanrong, Wang Zhengfang. Effects of tonifying kidney and eliminating stasis
formula combined with danazol on serum estrogen/progesterone and prostaglandin in patients with endometriosis.
World TCM,2018,013(3):683-686690.
[2] Wang Manli, Wang Wei. Study on the efficacy of endometriosis treatment with endoisolation formula combined with
conservative surgery and goserelin. Chinese Journal of Traditional Chinese
Medicine,2016,34(06):1354-1356.DOI:10.13193/j.issn.1673-7717.2016.06.020.
[3] Sun Mengzhu, Huang Wenqing. Progress of research on pathogenesis and clinical diagnosis and treatment of
endometriosis. International Journal of Laboratory Medicine,2023,44(16):2017-2022.
[4] Zhang Xiaofeng, Zhang Mingliang. Effect ofQu Yu Jie Du Xiao Zheng decotion on the levels of IL-6 and IL-8 in the
peritoneal fluid of rats with endometriosis. Shaanxi Traditional Chinese Medicine,2013,34(12):1676-1678.
[5] Zhang Su. Guidelines for combined diagnosis and treatment of endometriosis with Chinese and Western medicine.
Chinese Journal of Integrative Medicine and Western Medicine,2019,39(10):1169-1176.
[6] Zhang Xiaofeng, Wang Qing. A preliminary study on the treatment of endometriosis from the theory of "stasis,
dampness, turbidity and toxicity interconnecting and damaging the collaterals". Shaanxi Traditional Chinese
Medicine,2014,35(3):338-340.
[7] Zhang Xiaofeng, Dong Oriyun, Wang Qing. Treatment of 45 cases of endometriosis by Qu Yu Jie Du Xiao Zheng
decotion. Shaanxi Traditional Chinese Medicine,2009,30(3):260-261.
95
[8] Mao Haiyan, Chen Yuanhuan, Wu Qunsheng et al. The effect of Jiawei Shaobuyu Tang on neuroangiogenesis of
pelvic pain in endometriosis with cold-congealed blood stasis. Chinese Journal of Experimental
Formulas,2022,28(12):141-147.DOI:10.13422/j.cnki.syfjx.20221295.
[9] Fan Qiong, Wei Yuna, Yin Ling, et al. Clinical observation on the treatment of endometriosis pelvic pain with qi
stagnation and blood stasis by rhubarb. Chinese Journal of Experimental Formulas, 2019, 25(12):6.
DOI:10.13422/j.cnki.syfjx.20191231.
[10] Zhang Wei, Lu Jianjun. Effects of Liver-Sparing, Blood-Nourishing and Collaterals Formula combined with
mifepristone on pain level and serum PGE_2,PGF_(2α),NGF levels in endometriosis dysmenorrhea patients. Journal of
Modern Integrative Medicine, 2019, 28(32):5. DOI:CNKI:SUN:XDJH.0.2019-32-011.
[11] Shi Shujing, Xiang Mei, Song Wenling et al. A case of large omental endometrioid cyst combined with plasma
cystadenoma. International Journal of Obstetrics and Gynecology,2014,41(03):330-331+333.
[12]Liu Lina. Study on the relationship between endometrial nerve fiber distribution and endometriosis pain. Dalian
Medical University,2012.
[13] Dimitrijevic D, Vasiljevic M, Anicic R, et al. Recurrence rate of ovarian endometriosis in patients treated with
laparoscopic surgery and postoperative suppressive therapy. Clin Exp Obstet Gynecol,2015,42(3):339-343.
[14] Chang Fengge, Sun Lingxia, Ma Yuyao. Efficacy of two drugs combined with hysteroscopic electrodesiccation for
the treatment of early stage endometrial cancer respectively and the effect on reproductive function. Cancer Progress,
2020, 18(1):4. DOI:CNKI:SUN:AZJZ.0.2020-01-013.
[15] Hui Xuelian. Clinical research on the treatment of endometriosis by expelling blood stasis, detoxifying and
eliminating symptoms of endometriosis soup. Shaanxi College of Traditional Chinese Medicine
[2023-12-11].DOI:10.7666/d.y1658354.
96
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK